Keywords
AdenocarcinomaCancer researchEsophagusPathologyCancerCell of originBiologyCarcinomaCellMedicineInternal medicine
Related Publications
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer
PURPOSE Patients with advanced esophageal cancer have a poor prognosis and limited treatment options after first-line chemotherapy. PATIENTS AND METHODS In this open-label, phas...
First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial
First-line chemotherapy for advanced or metastatic human epidermal growth factor receptor 2 (HER2)-negative gastric or gastro-oesophageal junction adenocarcinoma has a median ov...
Carcinosarcoma and Pseudosarcoma of the Esophagus: Two Names, One Disease—Comprehensive Review of the Literature
In the present review we have collected 127 carcinosarcomas and 56 pseudosarcomas of the esophagus from the literature. There were no significant differences in age, sex, sympto...
Publication Info
- Year
- 2017
- Type
- article
- Volume
- 541
- Issue
- 7636
- Pages
- 169-175
- Citations
- 1775
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
1775
OpenAlex
Cite This
The Cancer Genome Atlas Research Network
(2017).
Integrated genomic characterization of oesophageal carcinoma.
Nature
, 541
(7636)
, 169-175.
https://doi.org/10.1038/nature20805
Identifiers
- DOI
- 10.1038/nature20805